Merck & Co. Inc. (NYSE:MRK) is reportedly making efforts to settle all Vioxx painkiller claims.

Merck & Co. Inc. (NYSE:MRK) Answering Painkiller Claims

Merck & Co. Inc. (NYSE:MRK), one of the largest pharmaceutical companies in the world, has reportedly decided to settle all Vioxx painkiller claims in Canada for a sum between C$21.8 million and C$36.9 million.

Merck & Co. Inc. (NYSE:MRK) withdrew the Vioxx painkiller from the market in 2004 after finding it could cause heart attacks and strokes, and has already settled fraud claims worth billions.

Merck & Co. Inc. (NYSE:MRK) shares were at 39.20 at the end of the last day’s trading. There’s been a 17.5% change in the stock price over the past 3 months.

Merck & Co. Inc. (NYSE:MRK) Analyst Advice
Consensus Opinion: Moderate Buy
Mean recommendation: 1.53
(1=Strong Buy, 5=Strong Sell)
3 Months Ago: 1.5
Zack’s Rank: 1 out of 14 in the industry